Literature DB >> 912031

Metabolism of DL-[14C]prenylamine in man.

G Remberg, M Eichelbaum, G Spiteller, H J Dengler.   

Abstract

Following oral administration of DL-[14C]prenylamine, about 40% of the dose administered was excreted in urine within 10 days. Less than 0.1% of the dose was excreted as unchanged prenylamine. The drug was extensively metabolized to at least 20 to 25 metabolites. The structure of 12 metabolites could be elucidated by means of g.c.m.s. Ring hydroxylation and further methylation of the phenolic metabolites are the main metabolic pathways involved. A substantial part of the drug and/or its metabolites is metabolized via cleavage of the C--N--C bond, giving rise to amphetamine and diphenylpropylamine which are further metabolized by aromatic and sidechain hydroxylation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912031     DOI: 10.1002/bms.1200040505

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  3 in total

1.  Mass spectral investigation of the metabolites of lorcainide in man.

Authors:  W F Lauwers; W E Meuldermans; J O Bracke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

2.  Single dose pharmacokinetics of fendiline in humans.

Authors:  W R Kukovetz; F Brunner; E Beubler; R Weyhenmeyer; R Lohaus; M Grob; D Mayer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

3.  Single- and multiple-dose pharmacokinetics of R-(-)-and S-(+)-prenylamine in man.

Authors:  Y Gietl; H Spahn; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.